Form D · Pharmaceuticals
Aclaris Therapeutics, Inc.
Wayne, PA · CIK 0001557746
Offering snapshot reported Dec 4, 2024 · SEC filing
- Reported sold
- $80M Offering amount: $80M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2024 | Initial | $79,999,999 | No comparison | 19 | SEC filing |
| Apr 8, 2020 | Initial | $11,000,000 | No comparison | 1 | SEC filing |
| Aug 13, 2018 | Amendment | $10,000,000 | $0vs Aug 14, 2017 | 41 | SEC filing |
| Aug 14, 2017 | Initial | $10,000,000 | No comparison | 42 | SEC filing |
| Jun 14, 2016 | Initial | $20,000,017 | No comparison | 9 | SEC filing |
| Sep 11, 2015 | Initial | $40,000,000 | No comparison | 28 | SEC filing |
| Oct 8, 2014 | Initial | $10,644,244 | No comparison | 25 | SEC filing |
| Sep 10, 2012 | Initial | $20,890,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4.8M
- Finders' fees
- $0
- Form D file number
- 021-531031
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 | |
| Cantor Fitzgerald & Co. | 134 |
Source: Form D, filed Dec 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kamil Ali Jackson | Executive |
| Kevin Balthaser | Executive |
| Richard A. Bierly | Director |
| Albert Cha | Director |
| Hugh Davis | Director, Executive |
| Brett Fair | Executive |
| David Gordon | Executive |
| Maxine Gowen | Director |
| William Humphries | Director |
| James Loerop | Executive |
| Anand Mehra | Director |
| Vincent Milano | Director |
| Christopher Molineaux | Director |
| Joseph Monahan | Executive |
| Ketan Patel | Director |
| Christopher Powala | Executive |
| Andrew Powell | Director |
| Bryan Reasons | Director |
| Frank Ruffo | Executive |
| Andrew Schiff | Director |
| Stuart Shanler | Executive |
| Steven A. Tullman | Director |
| Stephen A. Tullman | Director |
| Neal Walker | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
701 Lee Road Suite 103
Wayne, PA, 19087
Wayne, PA, 19087